npr music

Up First briefing: Trump won’t testify; FDA approves landmark gene-editing treatment

Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.

(Image credit: Pool/Getty Images)

Comment

Your email address will not be published. Required fields are marked *